CAS: 947687-02-7 - (4S)-4,8,11-Triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate
Formula:C35H42N4O6
InChI:InChI=1S/C35H42N4O6/c1-4-21-16-28-24(17-30(21)45-34(42)38-14-10-22(11-15-38)37-12-8-7-9-13-37)23(5-2)25-19-39-29(31(25)36-28)18-27-26(32(39)40)20-44-33(41)35(27,43)6-3/h16-18,22,43H,4-15,19-20H2,1-3H3/t35-/m0/s1
InChI key:InChIKey=IEKWXGPJFJGZSM-DHUJRADRSA-N
SMILES:O=C(OC1=CC=2C(=NC=3C4=CC5=C(C(=O)N4CC3C2CC)COC(=O)C5(O)CC)C=C1CC)N6CCC(N7CCCCC7)CC6
- Synonyms:
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,8,11-triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester
- (4S)-4,8,11-Triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
8-Ethyl Irinotecan REF: IN-DA01CB74CAS: 947687-02-7 | 95% | To inquire | Tue 07 Jan 25 | |
Irinotecan EP Impurity C REF: 4Z-I-187CAS: 947687-02-7 | - - - | To inquire | Tue 07 Jan 25 | |
8-Ethyl Irinotecan REF: TR-E921100CAS: 947687-02-7 | - - - | 458.00 €~5,328.00 € | Tue 14 Jan 25 | |
8-Ethyl irinotecan REF: 3D-XMB68702CAS: 947687-02-7 | Min. 95% | - - - | Discontinued product |
8-Ethyl Irinotecan
Ref: IN-DA01CB74
25mg | To inquire |
Irinotecan EP Impurity C
Ref: 4Z-I-187
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
8-Ethyl Irinotecan
Controlled ProductRef: TR-E921100
1mg | 458.00 € | ||
5mg | 1,426.00 € | ||
25mg | 5,328.00 € |
8-Ethyl irinotecan
Ref: 3D-XMB68702
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |